BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37023349)

  • 61. Calciphylaxis: a pseudo-vasculitis syndrome.
    Kyttaris VC; Timbil S; Kalliabakos D; Vaiopoulos G; Weinstein A
    Semin Arthritis Rheum; 2007 Feb; 36(4):264-7. PubMed ID: 17276174
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Calcific uremic arteriolopathy in hemodialysis patient, review of literature through five cases reports].
    Chettati M; Adnouni A; Fadili W; Laouad I
    Nephrol Ther; 2018 Nov; 14(6):439-445. PubMed ID: 30401462
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Calciphylaxis in secondary hyperparathyroidism. Diagnosis and parathyroidectomy.
    Duh QY; Lim RC; Clark OH
    Arch Surg; 1991 Oct; 126(10):1213-8; discussion 1218-9. PubMed ID: 1929821
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Calciphylaxis in patients with chronic kidney disease: A disease which is still bewildering and potentially fatal.
    Cucchiari D; Torregrosa JV
    Nefrologia (Engl Ed); 2018; 38(6):579-586. PubMed ID: 30415999
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Breast pain in a patient on dialysis: a rare manifestation of calcific uraemic arteriolopathy.
    Buscher K; Gabriëls G; Barth P; Pavenstädt H
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25576525
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sodium thiosulfate-based treatment in calcific uremic arteriolopathy: a consecutive case series.
    Sood AR; Wazny LD; Raymond CB; Leung K; Komenda P; Reslerova M; Verrelli M; Rigatto C; Sood MM
    Clin Nephrol; 2011 Jan; 75(1):8-15. PubMed ID: 21176746
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sodium thiosulfate is effective in calcific uremic arteriolopathy complicating chronic hemodialysis.
    Malbos S; Ureña-Torres P; Bardin T; Ea HK
    Joint Bone Spine; 2016 Jan; 83(1):89-92. PubMed ID: 26494591
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Early recognition and treatment of calciphylaxis.
    Parker RW; Mouton CP; Young DW; Espino DV
    South Med J; 2003 Jan; 96(1):53-5. PubMed ID: 12602715
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The nightmare of calciphylaxis].
    Ulrich M; Götz M; Krah X
    Aktuelle Urol; 2021 Feb; 52(1):70-72. PubMed ID: 31344746
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Calciphylaxis - A case study in a patient with Maori heritage.
    Kingi L; Grech R; Lam M; Dissanayake A; Otter S
    J Tissue Viability; 2016 Nov; 25(4):216-219. PubMed ID: 27443245
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Calcific uremic arteriolopathy in hemodialyzed patients.
    Checheriţă IA; Smarandache D; Rădulescu D; Peride I; Bratu O; Ciocâlteu A; Sebe I; Lascăr I
    Chirurgia (Bucur); 2013; 108(5):736-40. PubMed ID: 24157123
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study.
    Gaisne R; Péré M; Menoyo V; Hourmant M; Larmet-Burgeot D
    BMC Nephrol; 2020 Feb; 21(1):63. PubMed ID: 32101140
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Calciphylaxis: what nurses need to know.
    Bliss DE
    Nephrol Nurs J; 2002 Oct; 29(5):433-8, 443-4; quiz 445-6. PubMed ID: 12434450
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca x P product and aggressive wound care.
    Russell R; Brookshire MA; Zekonis M; Moe SM
    Clin Nephrol; 2002 Sep; 58(3):238-43. PubMed ID: 12356195
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Update on calciphylaxis etiopathogenesis, diagnosis, and management.
    Khanna U; Dominguez A; Keller J; Kroshinsky D; Ortega-Loayza AG; Strowd L; Micheletti RG
    Cutis; 2018 Dec; 102(6):395-400. PubMed ID: 30657805
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Calciphylaxis in a dialysis patient diagnosed by muscle biopsy.
    Stavros K; Motiwala R; Zhou L; Sejdiu F; Shin S
    J Clin Neuromuscul Dis; 2014 Mar; 15(3):108-11. PubMed ID: 24534833
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Uremic calciphylaxis].
    Lionet A; Urena Torres PA
    Nephrol Ther; 2022 Jun; 18(3):180-188. PubMed ID: 35514006
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sodium-Thiosulfate Induced Life-Threatening Metabolic Acidosis Limiting Treatment of Calciphylaxis.
    Sohal R; George T
    Am J Case Rep; 2020 Apr; 21():e919926. PubMed ID: 32336746
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Management of calcific uremic arteriolopathy (calciphylaxis) with a combination of treatments, including hyperbaric oxygen therapy.
    Arenas MD; Gil MT; Gutiérrez MD; Malek T; Moledous A; Salinas A; Alvarez-Ude F
    Clin Nephrol; 2008 Sep; 70(3):261-4. PubMed ID: 18793571
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Calciphylaxis: ischemic tissue necrosis in chronic renal failure. Case report and review of the literature].
    Schwarz G; Laukhuf F; Bittinger F; Knop J; Saloga J
    Hautarzt; 2000 Jan; 51(1):36-40. PubMed ID: 10663038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.